Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
IARTthis companyIntegra LifeSciences Holdings Corporation	$13.61	-1.85×	0.91×	0.58×	-8.46×	77.8%	51.7%	4.2%	-31.6%	-49.5%	1.9%	-4.7%	1.95×	-5.53×	0.79×	2.54×	0.0%	7	1.31	3	B
AORTArtivion, Inc.	$20.09	207.32×	4.61×	4.69×	35.96×	-102.2%	61.3%	6.1%	2.2%	2.2%	2.2%	-0.0%	0.65×	3.56×	1.01×	2.99×	0.0%	3	1.79	1	C-
ATECAlphatec Holdings, Inc.	$7.36	-21.92×	87.63×	4.13×	-91.1×	93.1%	69.6%	-10.7%	-18.8%	-397.9%	-12.8%	0.1%	17.21×	-11.57×	-3.88×	2.06×	0.0%	5	-0.52	2	C
AXGNAxoGen, Inc.	$50.40	-96.26×	11.7×	6.69×	8,017.22×	-145.4%	74.3%	-3.5%	-7.0%	-12.2%	-3.9%	-0.2%	0.52×	167.09×	-1.02×	5.11×	0.0%	4	33.22	2	C
CNMDCONMED Corporation	$51.41	26.71×	1.22×	0.92×	11.64×	119.6%	52.8%	10.3%	3.4%	4.6%	4.6%	12.0%	0.81×	4.5×	4.54×	2.14×	2.0%	8	1.96	3	B+
GMEDGlobus Medical, Inc.	$73.96	21.94×	2.58×	4.02×	12.85×	-36.5%	67.4%	16.3%	18.3%	11.8%	8.8%	5.0%	0.03×	-0.46×	0×	4.26×	0.0%	7	10.67	4	A+
Peer median	—	21.94×	4.61×	4.13×	12.85×	-36.5%	67.4%	6.1%	2.2%	2.2%	2.2%	0.1%	0.65×	3.56×	0×	2.99×	0.0%	5	1.96	2	—